Cariprazine
Overview
Cariprazine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2028019).
API suppliers (4)
Suppliers of Cariprazine evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 4 suppliers.
3 of 4 hold a GMP certificate on record in the EU or UK registers
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- MAPRIMED SAArgentina1 active DMF GMP on record
- MEHTA API Pvt. Ltd.India1 active DMF GMP on record
- BIOPHORE INDIA PHARMACEUTICALS PVT LTD1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (6 approved US products), the latest listed US patent on Cariprazine expires 17 Mar 2030 and exclusivity 18 Jun 2029. Generic API sourcing typically opens up once these lapse.
Do you supply Cariprazine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.